These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Vaccination with liposome-coupled glypican-3-derived epitope peptide stimulates cytotoxic T lymphocytes and inhibits GPC3-expressing tumor growth in mice. Iwama T; Uchida T; Sawada Y; Tsuchiya N; Sugai S; Fujinami N; Shimomura M; Yoshikawa T; Zhang R; Uemura Y; Nakatsura T Biochem Biophys Res Commun; 2016 Jan; 469(1):138-143. PubMed ID: 26616051 [TBL] [Abstract][Full Text] [Related]
25. Immunostimulatory and antigen delivery properties of liposomes made up of total polar lipids from non-pathogenic bacteria leads to efficient induction of both innate and adaptive immune responses. Faisal SM; Chen JW; McDonough SP; Chang CF; Teng CH; Chang YF Vaccine; 2011 Mar; 29(13):2381-91. PubMed ID: 21300103 [TBL] [Abstract][Full Text] [Related]
26. Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunity. Saha A; Chatterjee SK; Foon KA; Primus FJ; Bhattacharya-Chatterjee M Cancer Res; 2003 Jun; 63(11):2844-54. PubMed ID: 12782590 [TBL] [Abstract][Full Text] [Related]
27. Immunization with antigenic peptides complexed with β-glucan induces potent cytotoxic T-lymphocyte activity in combination with CpG-ODNs. Mochizuki S; Morishita H; Kobiyama K; Aoshi T; Ishii KJ; Sakurai K J Control Release; 2015 Dec; 220(Pt A):495-502. PubMed ID: 26562685 [TBL] [Abstract][Full Text] [Related]
28. A high-affinity T-helper epitope enhances peptide-pulsed dendritic cell-based vaccine. Li A; Xiong S; Lin Y; Liu R; Chu Y DNA Cell Biol; 2011 Nov; 30(11):883-92. PubMed ID: 21612399 [TBL] [Abstract][Full Text] [Related]
29. Activation of dendritic cells by liposomes prepared from phosphatidylinositol mannosides from Mycobacterium bovis bacillus Calmette-Guerin and adjuvant activity in vivo. Sprott GD; Dicaire CJ; Gurnani K; Sad S; Krishnan L Infect Immun; 2004 Sep; 72(9):5235-46. PubMed ID: 15322018 [TBL] [Abstract][Full Text] [Related]
30. Cytotoxic T lymphocytes responding to low dose TRP2 antigen are induced against B16 melanoma by liposome-encapsulated TRP2 peptide and CpG DNA adjuvant. Jérôme V; Graser A; Müller R; Kontermann RE; Konur A J Immunother; 2006; 29(3):294-305. PubMed ID: 16699372 [TBL] [Abstract][Full Text] [Related]
31. Immunostimulatory biodegradable implants containing the adjuvant Quil-A--Part II: In vivo evaluation. Myschik J; McBurney WT; Hennessy T; Phipps-Green A; Rades T; Hook S J Drug Target; 2008 Apr; 16(3):224-32. PubMed ID: 18365884 [TBL] [Abstract][Full Text] [Related]
32. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen. Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612 [TBL] [Abstract][Full Text] [Related]
33. Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis. Xu Z; Ramishetti S; Tseng YC; Guo S; Wang Y; Huang L J Control Release; 2013 Nov; 172(1):259-265. PubMed ID: 24004885 [TBL] [Abstract][Full Text] [Related]
35. Alternative inactivated poliovirus vaccines adjuvanted with Quillaja brasiliensis or Quil-a saponins are equally effective in inducing specific immune responses. de Costa F; Yendo AC; Cibulski SP; Fleck JD; Roehe PM; Spilki FR; Gosmann G; Fett-Neto AG PLoS One; 2014; 9(8):e105374. PubMed ID: 25148077 [TBL] [Abstract][Full Text] [Related]
36. Microparticulate β-glucan vaccine conjugates phagocytized by dendritic cells activate both naïve CD4 and CD8 T cells in vitro. Berner VK; duPre SA; Redelman D; Hunter KW Cell Immunol; 2015; 298(1-2):104-14. PubMed ID: 26549577 [TBL] [Abstract][Full Text] [Related]
37. A nano-liposome vaccine carrying E75, a HER-2/neu-derived peptide, exhibits significant antitumour activity in mice. Arab A; Behravan J; Razazan A; Gholizadeh Z; Nikpoor AR; Barati N; Mosaffa F; Badiee A; Jaafari MR J Drug Target; 2018 Apr; 26(4):365-372. PubMed ID: 28972792 [TBL] [Abstract][Full Text] [Related]
38. Astragalus Saponins and Liposome Constitute an Efficacious Adjuvant Formulation for Cancer Vaccines. Zhang XP; Li YD; Luo LL; Liu YQ; Li Y; Guo C; Li ZD; Xie XR; Song HX; Yang LP; Sun SB; An FY Cancer Biother Radiopharm; 2018 Feb; 33(1):25-31. PubMed ID: 29466034 [TBL] [Abstract][Full Text] [Related]
39. Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses. Guan HH; Budzynski W; Koganty RR; Krantz MJ; Reddish MA; Rogers JA; Longenecker BM; Samuel J Bioconjug Chem; 1998; 9(4):451-8. PubMed ID: 9667946 [TBL] [Abstract][Full Text] [Related]